|1.||Pérez-Rivera, Alex A: 1 article (01/2009)|
|2.||Hu, Ting: 1 article (01/2009)|
|3.||Aardema, Marilyn J: 1 article (01/2009)|
|4.||Nash, J F: 1 article (01/2009)|
|5.||Elsner, P: 1 article (08/2001)|
|6.||Wigger-Alberti, W: 1 article (08/2001)|
|7.||Kluge, K: 1 article (08/2001)|
01/01/2009 - "In the mouse lymphoma assay (MLA), climbazole was negative (non-mutagenic) with and without metabolic (S9) activation after a 4 h exposure; an increase in small colony mutants was observed without metabolic activation after a 24 h exposure at concentrations of 15 and 17.5 μg/mL. An in vivo mouse micronucleus test was negative up to a maximum tolerated dose (MTD) of 150 mg/kg climbazole administered orally. "